Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▴	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
BMY	Bristol Myers Squibb Co Manufacturing · Year ended 2025-12-31 · USD	$48.19B	$7.05B	14.6%	38.2%	-0.2%	$3.46
ABBV	AbbVie Inc. Manufacturing · Year ended 2025-12-31 · USD	$61.16B	$4.23B	6.9%	n/a	8.6%	$2.36
PFE	Pfizer Inc Manufacturing · Year ended 2025-12-31 · USD	$62.58B	$7.77B	12.4%	9.0%	-1.6%	$1.36
MRK	Merck & Co., Inc. Manufacturing · Year ended 2025-12-31 · USD	$65.01B	$18.25B	28.1%	34.7%	1.3%	$7.28
LLY	Eli Lilly & Co Manufacturing · Year ended 2025-12-31 · USD	$65.18B	$20.64B	31.7%	77.8%	44.7%	$22.95
JNJ	Johnson & Johnson Manufacturing · Year ended 2025-12-28 · USD	$94.19B	$26.80B	28.5%	32.9%	6.0%	$11.03
ABEO	Abeona Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$71.18M	n/a	44.7%	n/a	$1.01
ACET	Adicet Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$116.80M	n/a	-73.4%	n/a	-$16.95
ACRV	Acrivon Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$77.91M	n/a	-69.2%	n/a	-$2.02
ACTU	Actuate Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.23M	n/a	-280.5%	n/a	-$1.06
ACUT	Accustem Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.76M	n/a	n/a	n/a	-$0.12
ACXP	Acurx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.97M	n/a	-151.2%	n/a	-$5.32
ADIL	Adial Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$7.98M	n/a	-151.2%	n/a	-$11.93
AEON	AEON Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$39.22M	n/a	n/a	n/a	-$3.95
AKTX	Akari Therapeutics Plc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$17.30M	n/a	-61.1%	n/a	$0.00
ALDX	Aldeyra Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$33.85M	n/a	-76.5%	n/a	-$0.56
ALXO	ALX Oncology Holdings Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$101.69M	n/a	-391.4%	n/a	-$1.90
ALZN	Alzamend Neuro, Inc. Manufacturing · Year ended 2026-04-30 · USD	n/a	-$8.77M	n/a	n/m	n/a	-$2.63
ANEB	Anebulo Pharmaceuticals, Inc. Manufacturing · Year ended 2025-06-30 · USD	n/a	-$8.48M	n/a	-72.8%	n/a	-$0.25
ANIX	Anixa Biosciences Inc Manufacturing · Year ended 2025-10-31 · USD	n/a	-$10.93M	n/a	-72.1%	n/a	-$0.34
ANNX	Annexon, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$206.69M	n/a	-97.7%	n/a	-$1.34
ANRO	Alto Neuroscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$63.24M	n/a	-41.8%	n/a	-$2.19
ANTX	AN2 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.17M	n/a	-66.3%	n/a	-$1.16
APRE	Aprea Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.60M	n/a	-101.3%	n/a	-$1.93
APUS	Apimeds Pharmaceuticals US, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$6.00M	n/a	-3.9%	n/a	-$0.55

Rows per page: 2550 100